Literature DB >> 4950489

The central effects of scopolamine in man.

D J Safer, R P Allen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4950489

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  44 in total

1.  Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus.

Authors:  K E Vogt; W G Regehr
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Pharmacological modulation of behavioral and neuronal correlates of repetition priming.

Authors:  C M Thiel; R N Henson; J S Morris; K J Friston; R J Dolan
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

3.  RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.

Authors:  Zohar Nachum; Avi Shupak; Carlos R Gordon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Widespread hyoscine hydrobromide toxicity due to contract manufacturer malpractice : the travacalm episode.

Authors:  John McEwen; Barry R Thompson; Patrick M Purcell; Larry F Kelly; Adrian S Krauss
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  TRH attenuates scopolamine-induced memory impairment in humans.

Authors:  S E Molchan; A M Mellow; B A Lawlor; H J Weingartner; R M Cohen; M R Cohen; T Sunderland
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Effects of mianserin in neuroleptic-induced parkinsonism.

Authors:  S Korsgaard; T Friis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study.

Authors:  D L Lamping; B Spring; A J Gelenberg
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Cholinergic learning deficits in the marmoset produced by scopolamine and ICV hemicholinium.

Authors:  R M Ridley; N G Barratt; H F Baker
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  The separate and combined effects of scopolamine and nicotine on human information processing.

Authors:  K Wesnes; A Revell
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.